(Q34465769)

2 August 2017

1 reference

title

Anal cancer treatment: current status and future perspectives (English)

1 reference

2 August 2017

author

Hampig Raphael Kourie

2

object named as

Hampig Raphael Kourie

1 reference

2 August 2017

Marwan Ghosn

1

1 reference

2 August 2017

Pamela Abdayem

3

1 reference

2 August 2017

Joelle Antoun

4

1 reference

2 August 2017

Dolly Nasr

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 February 2015

1 reference

World Journal of Gastroenterology

2 August 2017

published in

1 reference

2 August 2017

volume

21

1 reference

2 August 2017

issue

8

1 reference

2 August 2017

page(s)

2294-2302

1 reference

KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC)

2 August 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Salvage surgery for residual primary and locally recurrent anal squamous cell carcinoma after chemoradiotherapy in HIV-positive individuals

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Unexpected toxicity of cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: results of the UNICANCER ACCORD 16 phase II trial.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

6 July 2018

Cancer statistics, 2013

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Global burden of human papillomavirus and related diseases.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

EGFR and K-ras gene mutation status in squamous cell anal carcinoma: a role for concurrent radiation and EGFR inhibitors?

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Efficacy of Cetuximab in Combination with FOLFIRI in a Patient with KRAS Wild-Type Metastatic Anal Cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Neoplasms of anal canal and perianal skin.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

A regimen of taxol, Ifosfamide, and platinum for recurrent advanced squamous cell cancer of the anal canal

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Concurrent cisplatin, continuous infusion fluorouracil and radiotherapy followed by tailored consolidation treatment in non metastatic anal squamous cell carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

A case of salvage treatment for local recurrence of squamous cell anal carcinoma after chemoradiation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Rapamycin inhibits anal carcinogenesis in two preclinical animal models

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Photodynamic therapy for anal cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Epidermal growth factor receptor and K-RAS status in two cohorts of squamous cell carcinomas

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Anal cancer with cerebral metastasis: a case report

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I).

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Growth factor receptor expression in anal squamous lesions: modifications associated with oncogenic human papillomavirus and human immunodeficiency virus

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Combined modality therapy for HIV-infected patients with squamous cell carcinoma of the anus: outcomes and toxicities

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Phase II study of mitomycin-C, adriamycin, cisplatin (MAP) and Bleomycin-CCNU in patients with advanced cancer of the anal canal: An eastern cooperative oncology group study E7282.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Combined multimodal approach to the treatment of metastatic anal carcinoma: report of a case and review of the literature

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

The global health burden of infection-associated cancers in the year 2002

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Management of anal cancer in the HIV-positive population.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Epidermoid anal cancer: a review of a population-based series of 308 consecutive patients treated according to prospective protocols

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Outcome analysis of HIV-positive patients with anal squamous cell carcinoma

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Malignant tumors of the anal canal: the spectrum of disease, treatment, and outcomes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Carcinoma of the anal canal, a clinical and pathologic study of 188 cases

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Results of surgical treatment of squamous cell carcinoma of the anal canal and anal margin seen at St. Mark's Hospital 1928-66.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

External beam radiotherapy ± chemotherapy in the treatment of anal canal cancer: a single-institute long-term experience on 100 patients.

6 July 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Induction therapy for poor-prognosis anal canal carcinoma: a phase II study of the cancer and Leukemia Group B (CALGB 9281).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Mitomycin C with continuous fluorouracil or with cisplatin in combination with radiotherapy for locally advanced anal cancer (European Organisation for Research and Treatment of Cancer phase II study 22011-40014).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

K-ras status in squamous cell anal carcinoma (SCC): it's time for target-oriented treatment?

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Cetuximab-based treatment of metastatic anal cancer: correlation of response with KRAS mutational status.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the anal canal

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Abdominoperineal resection for squamous cell anal carcinoma: survival and risk factors for recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Multimodality therapy including salvage surgical resection and intraoperative radiotherapy for patients with squamous-cell carcinoma of the anus with residual or recurrent disease after primary chemoradiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

DCF (docetaxel, cisplatin and 5-fluorouracil) chemotherapy is a promising treatment for recurrent advanced squamous cell anal carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Human immunodeficiency virus-associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era.

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Outcomes of chemoradiotherapy with 5-Fluorouracil and mitomycin C for anal cancer in immunocompetent versus immunodeficient patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Concurrent chemotherapy and intensity-modulated radiation therapy for anal canal cancer patients: a multicenter experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

HPV vaccine against anal HPV infection and anal intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Evaluation of quadrivalent HPV 6/11/16/18 vaccine efficacy against cervical and anogenital disease in subjects with serological evidence of prior vaccine type HPV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

Vaccination trial with HPV16 L1E7 chimeric virus-like particles in women suffering from high grade cervical intraepithelial neoplasia (CIN 2/3).

21 January 2018

1 reference

https://api.crossref.org/works/10.3748%2FWJG.V21.I8.2294

EGFR, KRAS, BRAF, and PIK3CA characterization in squamous cell anal cancer

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Outcomes of salvage surgery for squamous cell carcinoma of the anal canal

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Regression of papilloma high-grade lesions (CIN 2 and CIN 3) is stimulated by therapeutic vaccination with MVA E2 recombinant vaccine.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Results of combined modality therapy for patients with anal cancer (E7283). An Eastern Cooperative Oncology Group study.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Malignant epithelial tumors of the anal canal

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Depth of invasion, location, and size of cancer of the anus dictate operative treatment

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4342904

Clinical experience with chemoradiotherapy comprising S-1 plus low-dose cisplatin in a patient with stage IV anal cancer

27 October 2018

1 reference

12 December 2020

Preliminary results of a phase II study of high-dose radiation therapy and neoadjuvant plus concomitant 5-fluorouracil with CDDP chemotherapy for patients with anal canal cancer: a French cooperative study

1 reference

12 December 2020

Cisplatin plus 5-fluorouracil in the treatment of metastatic anal squamous cell carcinoma: a report of two cases

1 reference

12 December 2020

Transitional cloacogenic carcinoma of the anal canal. Clinicopathologic study of three hundred seventy-three cases

1 reference

12 December 2020

Concurrent chemoradiotherapy with 5-fluorouracil and mitomycin C for anal carcinoma: are there differences between HIV-positive and HIV-negative patients in the era of highly active antiretroviral therapy?

1 reference

12 December 2020

Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and

1 reference

12 December 2020

Outcomes of salvage surgery for epidermoid carcinoma of the anus following failed combined modality treatment

1 reference

12 December 2020

Definitive irradiation and chemotherapy for radiosensitization in management of anal carcinoma: interim report on Radiation Therapy Oncology Group study no. 8314

1 reference

12 December 2020

Salvage abdominoperineal resection for anal cancer following chemoradiation: a proposed scoring system for predicting postoperative survival

1 reference

12 December 2020

Cancer of the anal canal. Model for preoperative adjuvant combined modality therapy

1 reference

12 December 2020

Carcinoma of the anal canal: a study of 79 cases

1 reference

12 December 2020

Treatment of relapsing anal carcinoma

1 reference

12 December 2020

Chemoradiotherapy versus radiotherapy alone for anal cancer: a retrospective comparison

1 reference

12 December 2020

Anal squamous cell cancer nodal metastases: prognostic significance and therapeutic considerations

1 reference

12 December 2020

Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment

1 reference

12 December 2020

Combination of cisplatin plus fluoropyrimidine chemotherapy effective against liver metastases from carcinoma of the anal canal

1 reference

12 December 2020

[5-fluorouracile and cisplatinum combination chemotherapy for metastatic squamous-cell anal cancer]

1 reference

12 December 2020

Primary chemoradiation therapy with fluorouracil and cisplatin for cancer of the anus: results in 35 consecutive patients

1 reference

12 December 2020

[Diagnosis and therapy for anal carcinoma]

1 reference

12 December 2020

Recurrent metastatic anal cancer treated with modified paclitaxel, ifosfamide, and cisplatin and third-line mitomycin/cetuximab

1 reference

12 December 2020

Combining cisplatin and mitomycin with radiotherapy in anal carcinoma

1 reference

12 December 2020

Combined therapy for cancer of the anal canal: a preliminary report

1 reference

12 December 2020

Epidermoid cancer of the anal margin. Pathologic features, treatment, and clinical results

1 reference

12 December 2020

Induction chemotherapy and dose intensification of the radiation boost in locally advanced anal canal carcinoma: final analysis of the randomized UNICANCER ACCORD 03 trial

1 reference

12 December 2020

Predictors and patterns of recurrence after definitive chemoradiation for anal cancer

1 reference

12 December 2020

Malignant progression of anal intra-epithelial neoplasia

1 reference

12 December 2020

Treatment of epidermoid carcinoma of the anal canal

1 reference

12 December 2020

Cisplatin and 5-fluorouracil as salvage therapy for recurrent metastatic squamous cell carcinoma of the anal canal

1 reference

12 December 2020

[Pathologically complete response for unresectable stage IV rectal cancer using systemic chemotherapy with panitumumab - a case report]

1 reference

12 December 2020

Treatment of HIV-associated invasive anal cancer with combined chemoradiation

1 reference

12 December 2020

Single-agent paclitaxel in advanced anal cancer after failure of cisplatin and 5-fluorouracil chemotherapy

1 reference

12 December 2020

HIV-specific differences in outcome of squamous cell carcinoma of the anal canal: a multicentric cohort study of HIV-positive patients receiving highly active antiretroviral therapy

1 reference

12 December 2020

Squamous cell carcinoma of the anus at one hospital from 1948 to 1984

1 reference

12 December 2020

Identifiers

DOI

10.3748/WJG.V21.I8.2294

1 reference

2 August 2017

1 reference

2 August 2017

1 reference